Ensure the patient is aware of the risk of neoplastic change (occurs in approximately 5% of women with genital lichen sclerosus [LS]), and that risk can be minimised by good disease control via continuance of maintenance therapy (if indicated) as recommended by the clinician.[4]Micheletti L, Preti M, Radici G, et al. Vulvar lichen sclerosus and neoplastic transformation: a retrospective study of 976 cases. J Low Genit Tract Dis. 2016 Apr;20(2):180-3.
http://www.ncbi.nlm.nih.gov/pubmed/26882123?tool=bestpractice.com
[5]Vieira-Baptista P, Pérez-López FR, López-Baena MT, et al. Risk of development of vulvar cancer in women with lichen sclerosus or lichen planus: a systematic review. J Low Genit Tract Dis. 2022 Jul 1;26(3):250-7.
http://www.ncbi.nlm.nih.gov/pubmed/35285455?tool=bestpractice.com
[34]van der Meijden WI, Boffa MJ, Ter Harmsel B, et al. 2021 European guideline for the management of vulval conditions. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):952-72.
https://www.doi.org/10.1111/jdv.18102
http://www.ncbi.nlm.nih.gov/pubmed/35411963?tool=bestpractice.com
Advise patients to contact their clinician if there is a major change in symptoms or if there is a change in appearance or texture of the affected skin (which may include scarring and associated structural changes).[34]van der Meijden WI, Boffa MJ, Ter Harmsel B, et al. 2021 European guideline for the management of vulval conditions. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):952-72.
https://www.doi.org/10.1111/jdv.18102
http://www.ncbi.nlm.nih.gov/pubmed/35411963?tool=bestpractice.com
Advise patients with only extragenital disease to self-monitor for signs and symptoms of anogenital disease and to contact their clinician for review if they occur.
Demonstrate how much topical corticosteroid to use (e.g., a lentil or half pea-size amount may be appropriate in an adult woman with anogenital LS) and where to apply it - the use of photographs or having patients use a mirror in clinic can be helpful adjuncts. Allay any fears stemming from corticosteroid phobia, which is frequently encountered in patients with LS.[42]Wijaya M, Lee G, Fischer G, et al. Quality of life in vulvar lichen sclerosus patients treated with long-term topical corticosteroids. J Low Genit Tract Dis. 2021 Apr 1;25(2):158-65.
http://www.ncbi.nlm.nih.gov/pubmed/33746196?tool=bestpractice.com
[85]Delpero E, Sriharan A, Selk A. Steroid phobia in patients with vulvar lichen sclerosus. J Low Genit Tract Dis. 2023 Jul 1;27(3):286-90.
http://www.ncbi.nlm.nih.gov/pubmed/37285240?tool=bestpractice.com
Before initiation of topical corticosteroids, reassure the patient that:
Topical corticosteroids are safe and highly effective when an appropriate amount is used in the correct anatomical location
Adverse effects are minimal when used as directed
Using the correct amount will decrease symptoms as well as help to prevent future scarring; good control of the disease should decrease the chance of developing squamous cell carcinoma.
Advise patients to avoid irritant and fragranced products.[35]Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018 Apr;178(4):839-53.
https://www.doi.org/10.1111/bjd.16241
http://www.ncbi.nlm.nih.gov/pubmed/29313888?tool=bestpractice.com
Instruct patients with anogenital disease to clean affected areas with only water if they can tolerate this. If the patient’s preference is to use a soap, counsel them to use a gentle formulation without allergens or irritants, and to apply this with their hands rather than with a washcloth.
Soaps, if used, should be entirely rinsed with water.[35]Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018 Apr;178(4):839-53.
https://www.doi.org/10.1111/bjd.16241
http://www.ncbi.nlm.nih.gov/pubmed/29313888?tool=bestpractice.com
[56]Kirtschig G, Kinberger M, Kreuter A, et al; European Dermatology Forum. EuroGuiDerm guideline on lichen sclerosus. Jun 2023 [internet publication].
https://www.guidelines.edf.one//uploads/attachments/clmub3q4l0an5uhjrluc4r0yq-lichen-sclerosus-gl.pdf
Advise women and girls that soap and other cleansers should not be used internally.
Advise the patient that emollient use (e.g., white petrolatum) is recommended for all affected areas as an adjunct treatment alongside standard therapies.[35]Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018 Apr;178(4):839-53.
https://www.doi.org/10.1111/bjd.16241
http://www.ncbi.nlm.nih.gov/pubmed/29313888?tool=bestpractice.com
[56]Kirtschig G, Kinberger M, Kreuter A, et al; European Dermatology Forum. EuroGuiDerm guideline on lichen sclerosus. Jun 2023 [internet publication].
https://www.guidelines.edf.one//uploads/attachments/clmub3q4l0an5uhjrluc4r0yq-lichen-sclerosus-gl.pdf
Advise that emollients and topical corticosteroids should not be applied simultaneously, because doing so may dilute the agents.[56]Kirtschig G, Kinberger M, Kreuter A, et al; European Dermatology Forum. EuroGuiDerm guideline on lichen sclerosus. Jun 2023 [internet publication].
https://www.guidelines.edf.one//uploads/attachments/clmub3q4l0an5uhjrluc4r0yq-lichen-sclerosus-gl.pdf
Emollients may provide additional symptom relief, improve the skin barrier, and provide resistance to external irritants.[56]Kirtschig G, Kinberger M, Kreuter A, et al; European Dermatology Forum. EuroGuiDerm guideline on lichen sclerosus. Jun 2023 [internet publication].
https://www.guidelines.edf.one//uploads/attachments/clmub3q4l0an5uhjrluc4r0yq-lichen-sclerosus-gl.pdf
Emollients may be used as soap substitutes when washing extragenital areas.[35]Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018 Apr;178(4):839-53.
https://www.doi.org/10.1111/bjd.16241
http://www.ncbi.nlm.nih.gov/pubmed/29313888?tool=bestpractice.com
Use of emollients may be continued following the acute phase to maintain improved condition of the skin.[35]Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018 Apr;178(4):839-53.
https://www.doi.org/10.1111/bjd.16241
http://www.ncbi.nlm.nih.gov/pubmed/29313888?tool=bestpractice.com
[56]Kirtschig G, Kinberger M, Kreuter A, et al; European Dermatology Forum. EuroGuiDerm guideline on lichen sclerosus. Jun 2023 [internet publication].
https://www.guidelines.edf.one//uploads/attachments/clmub3q4l0an5uhjrluc4r0yq-lichen-sclerosus-gl.pdf
Provide patients with information regarding the condition, such as up-to-date patient information leaflets and links to trusted resources/websites.[34]van der Meijden WI, Boffa MJ, Ter Harmsel B, et al. 2021 European guideline for the management of vulval conditions. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):952-72.
https://www.doi.org/10.1111/jdv.18102
http://www.ncbi.nlm.nih.gov/pubmed/35411963?tool=bestpractice.com
[35]Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018 Apr;178(4):839-53.
https://www.doi.org/10.1111/bjd.16241
http://www.ncbi.nlm.nih.gov/pubmed/29313888?tool=bestpractice.com
[56]Kirtschig G, Kinberger M, Kreuter A, et al; European Dermatology Forum. EuroGuiDerm guideline on lichen sclerosus. Jun 2023 [internet publication].
https://www.guidelines.edf.one//uploads/attachments/clmub3q4l0an5uhjrluc4r0yq-lichen-sclerosus-gl.pdf
It is important that the patient does not feel isolated; given the sensitive nature of this condition, they may not wish to discuss their diagnosis with family and friends. There are numerous support groups available for patients with lichen sclerosus and their families/carers, such as: